Envista Holdings Corporation $NVST Shares Sold by Hotchkis & Wiley Capital Management LLC

Key Points

• Hotchkis & Wiley Capital Management LLC has reduced its stake in Envista Holdings by 61.0%, owning 307,130 shares after selling 479,630 shares in the first quarter.
• Envista Holdings reported $0.26 earnings per share (EPS), exceeding the consensus estimate of $0.24, with a revenue of $682.10 million during the last quarter, indicating a 7.7% year-over-year increase.
• Analyst ratings for Envista vary, with one strong buy, four buy, nine hold, and one sell, alongside a consensus price target of $20.92.

Hotchkis & Wiley Capital Management LLC trimmed its holdings in Envista Holdings Corporation (NYSE:NVST - Free Report) by 61.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 307,130 shares of the company's stock after selling 479,630 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned approximately 0.18% of Envista worth $5,301,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of NVST. UMB Bank n.a. grew its position in Envista by 214.4% in the 1st quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after buying an additional 1,428 shares during the last quarter. Palouse Capital Management Inc. lifted its position in shares of Envista by 14.4% during the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock valued at $163,000 after acquiring an additional 1,186 shares during the period. FourThought Financial Partners LLC purchased a new stake in shares of Envista in the 1st quarter worth about $180,000. Vestcor Inc purchased a new stake in shares of Envista in the 1st quarter worth about $211,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of Envista by 51.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company's stock worth $213,000 after buying an additional 3,751 shares in the last quarter.

Envista Trading Down 0.5%

Shares of NYSE:NVST traded down $0.11 during trading on Friday, reaching $21.15. 1,038,714 shares of the stock were exchanged, compared to its average volume of 1,878,506. The firm has a market cap of $3.51 billion, a price-to-earnings ratio of 66.08, a price-to-earnings-growth ratio of 1.13 and a beta of 0.99. Envista Holdings Corporation has a 12-month low of $14.22 and a 12-month high of $23.00. The firm's 50-day moving average price is $20.29 and its 200 day moving average price is $18.58. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The firm had revenue of $682.10 million during the quarter, compared to analysts' expectations of $638.21 million. Envista had a return on equity of 4.84% and a net margin of 2.11%.Envista's quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.11 EPS. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. On average, sell-side analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

NVST has been the subject of several analyst reports. Wall Street Zen downgraded shares of Envista from a "strong-buy" rating to a "buy" rating in a research note on Saturday. UBS Group boosted their target price on shares of Envista from $18.00 to $22.00 and gave the company a "neutral" rating in a research note on Tuesday, July 29th. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Mizuho upped their price objective on shares of Envista from $15.00 to $18.00 and gave the company an "underperform" rating in a research note on Friday, August 1st. Finally, Piper Sandler upped their price objective on shares of Envista from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $20.92.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.